Ruiyun procedure for hemorrhoids versus tissue-selective therapy stapler—a retrospective study comparing 2 miniinvasive treatment for grade II-III hemorrhoids

Background The Ruiyun procedure for hemorrhoids (RPH) and tissue-selecting therapy (TST) are two widely adopted minimally invasive techniques for treating grade II-III hemorrhoids. This study aimed to compare the clinical efficacy and safety of RPH versus TST for this condition. Methods A retrospective analysis was conducted on 192 patients with grade II-III hemorrhoids, comprising 80 patients who underwent RPH and 112 who underwent TST. The primary outcomes were the treatment effectiveness rate at one month and the recurrence rate within one year postoperatively. Secondary outcomes included operative time, intraoperative blood loss, time to resume normal work, postoperative anal pain, patient satisfaction, and incidence of complications. Results The two groups were comparable in baseline characteristics. No significant differences were found in the overall clinical efficacy or the one-year recurrence rate between the groups (p > 0.05). However, the RPH group demonstrated significant advantages in shorter operative time, reduced intraoperative blood loss, faster to resume normal worker, lower anal pain scores on postoperative days 1 and 3, lower incidence of urinary retention and fecal urgency and higher patient satisfaction (all p < 0.05). No significant intergroup differences were observed in anal distension, postoperative bleeding, anorectal stenosis, or anal pain on postoperative day 7 (p > 0.05). Conclusion RPH is an effective and safe procedure for grade II-III hemorrhoids, offering superior outcomes over TST in operative efficiency, intraoperative blood loss, specific postoperative complications, early recovery and patient satisfaction. Large samples and randomized controlled trials are necessary to confirm these results.